# Verici Dx upgrades genomics infrastructure to support scale

- Link: https://www.directorstalkinterviews.com/verici-dx-upgrades-genomics-infrastructure-to-support-scale/4121241467
- Published: 2026-02-24T15:48:00+00:00
- Author: Amilia Stone

[Verici Dx](https://www.directorstalkinterviews.com/company/verici-dx-plc/vrci.l)
has upgraded its bioinformatics infrastructure to address rising data volumes and
improve the speed and reliability of its diagnostic workflows. As its next-generation
sequencing assays generate increasing quantities of complex genomic data, the company
identified operational constraints in its existing processing systems. Manual steps
and fragmented tools were limiting throughput and extending analysis times, creating
friction at a point in the value chain that is central to product delivery.

To resolve this, Verici Dx implemented Illumina Connected Analytics developed by
Illumina and deployed on Amazon Web Services. The platform provides cloud-based 
data storage, workflow orchestration and scalable computing power tailored to genomics
applications. For investors, this move is less about technology adoption and more
about operational control, cost visibility and readiness for scale.

[AWS_Illumina_Verici-Dx_Q3_2022_HCLS_Case_Study_Final-1](https://www.directorstalkinterviews.com/wp-content/uploads/2026/02/AWS_Illumina_Verici-Dx_Q3_2022_HCLS_Case_Study_Final-1.pdf)
[Download](https://www.directorstalkinterviews.com/wp-content/uploads/2026/02/AWS_Illumina_Verici-Dx_Q3_2022_HCLS_Case_Study_Final-1.pdf)

_**[Verici Dx Plc](https://www.directorstalkinterviews.com/company/verici-dx-plc/vrci.l)**(
LON:VRCI) is developing a complementary suite of proprietary, leading-edge tests
forming a kidney transplant diagnostics platform for personalised patient and organ
response risk to assist clinicians in medical management for improved patient outcomes._

Share on: